Organization
Ra Pharmaceuticals
3 clinical trials
Clinical trial
A Phase 3, Multicenter, Open-Label Extension Study of Zilucoplan in Subjects With Generalized Myasthenia GravisStatus: Active (not recruiting), Estimated PCD: 2026-05-20
Clinical trial
A Multicenter, Open-label, Uncontrolled, Extension Study of RA101495 in Subjects With Paroxysmal Nocturnal Hemoglobinuria Who Have Completed a RA101495 Clinical StudyStatus: Terminated, Estimated PCD: 2021-09-07
Clinical trial
A Phase 3, Multicenter, Randomized, Double Blind, Placebo-Controlled Study to Confirm the Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia GravisStatus: Completed, Estimated PCD: 2021-12-30